Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.16 (
calcineurin
)
17,112
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the Drosophila visual cascade, the transient receptor potential (TRP) calcium channel, phospholipase Cbeta (no-receptor-potential A), and an eye-specific isoform of protein kinase C (eye-PKC) comprise a multimolecular signaling complex via their interaction with the scaffold protein
INAD
. Previously, we showed that the interaction between
INAD
and eye-PKC is a prerequisite for deactivation of a light response, suggesting eye-PKC phosphorylates proteins in the complex. To identify substrates of eye-PKC, we immunoprecipitated the complex from head lysates using anti-
INAD
antibodies and performed in vitro kinase assays. Wild-type immunocomplexes incubated with [(32)P]ATP revealed phosphorylation of TRP and
INAD
. In contrast, immunocomplexes from inaC mutants missing eye-PKC, displayed no phosphorylation of TRP or
INAD
. We also investigated protein phosphatases that may be involved in the dephosphorylation of proteins in the complex. Dephosphorylation of TRP and
INAD
was partially suppressed by the
protein phosphatase
inhibitors okadaic acid, microcystin, and
protein phosphatase
inhibitor-2. These phosphatase activities were enriched in the cytosol of wild-type heads, but drastically reduced in extracts prepared from glass mutants, which lack photoreceptors. Our findings indicate that
INAD
functions as RACK (receptor for activated PKC), allowing eye-PKC to phosphorylate
INAD
and TRP. Furthermore, dephosphorylation of
INAD
and TRP is catalyzed by PP1/PP2A-like enzymes preferentially expressed in photoreceptor cells.
...
PMID:Reversible phosphorylation of the signal transduction complex in Drosophila photoreceptors. 1076 55